For the fourth year in a row, Chambers & Partners, a prominent ranking publication for lawyers, has once again tapped Baker McKenzie lawyers as Contributing Editors to the Global Practice Guide for Life Sciences. The guide offers commentaries on a wide range of legal and business issues in a number of important healthcare markets such as Australia, China, India, Japan, Mexico, UK, Switzerland and the US.
Our team of seasoned industry experts developed a survey for other law firms around key areas of law and practice within each jurisdiction. This includes an overview of the local regulatory framework and issues related to clinical trials; marketing authorization; manufacturing, distribution, importation and exportation of pharmaceuticals and medical devices; pricing and reimbursement; digital healthcare; licensing; patents; and other IP.
The publication, which covers almost every area relevant to the pharmaceuticals and medtech sectors, is the most comprehensive and publicly available legal guide in the market.
Ben McLaughlin (Partner and Chair of the Global Healthcare & Life Sciences Group, Sydney), Christian Lopez-Silva (Partner and Member of the North America and Latin America Healthcare & Life Sciences Group, Mexico City), Randall Sunberg (Partner and Chair of the North America Healthcare & Life Sciences Group, Princeton/New York) and Veleka Peeples-Dyer (Partner and Chair of the North America Food and Drug Administration Practice Group, Washington, DC) co-authored the introductory chapter which concisely identifies the key trends transforming the sector and the recent developments impacting the life sciences landscape in the world's major markets.
These include the disruptive uncertainties resulting from the COVID-19 pandemic, explosion of big data, increasing collection of personal data, digitization of healthcare delivery, adoption of technological innovations, increasing support for biosimilars, stricter scrutiny of enforcement agencies, rise of patient-centric models, growing pricing pressures, revisiting R&D strategies, changing business models, fast-moving deal trends and the impact of geopolitics.
Additionally, regarding the national chapters, Christian Lopez-Silva (Partner) and his colleagues, Carlos Vela-Treviño (Partner), Carlos Davila-Peniche (Partner) and David Campos (Senior Associate) shared their insights for the Mexico chapter.
Christian shares, “The life sciences and healthcare industry has entered into a new decade of unprecedented legal and business challenges which are transforming how companies in the sector operate, compete and innovate. We are privileged to once again work with Chambers & Partners to share our insights on the opportunities and risks that we see impacting or could impact supply chains, business and delivery models, dealmaking and ultimately, bottomlines."